KANG Stock Ownership Activity

IKANG HEALTHCARE GROUP-ADR 13F holders

No value investing guru has made any change to the IKANG HEALTHCARE GROUP-ADR (KANG) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying KANG now?

According to the latest SEC filing(s) IKANG HEALTHCARE GROUP-ADR (KANG) has not been purchased by any super investor.

To see more about who is investing in IKANG HEALTHCARE GROUP-ADR (KANG), please go to the KANG ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2016 Q2 (1 result)
Howard Marks
Oaktree Capital Management
-100.00%
-48,100
-0.04%
0.00%
Reported price*: $20.44
2015 Q4 (1 result)
Robert Karr
Joho Capital
-100.00%
-1,045,117
-5.35%
0.00%
Reported price*: $14.80
2015 Q3 (1 result)
Robert Karr
Joho Capital
-54.29%
-1,241,233
-6.49%
0.00%
Reported price*: $14.80
2015 Q2 (2 results)
Howard Marks
Oaktree Capital Management
buy
+41,606
+0.02%
0.02%
Robert Karr
Joho Capital
buy
+2,822,655
+12.72%
12.72%
AVG reported price*: $19.34
5 of 5

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.